Each tablet contains Piracetam 800 mg or 1200 mg.

Neurocetam Tablets contain Piracetam, a nootropic agent that supports cognitive function and neuronal health by enhancing membrane fluidity and improving communication between nerve cells. It exhibits neuroprotective and vascular effects, helping preserve cognitive abilities, improve cerebral function, and support neurological recovery. The formulation is indicated as an adjunctive therapy in the management of cortical myoclonus.

Neurocetam Tablets are indicated for the symptomatic treatment of cortical myoclonus in adult patients, irrespective of its underlying etiology. It is recommended for use in combination with other anti-myoclonic therapies to improve symptom control and neurological function.

Piracetam binds to the polar heads of phospholipids in neuronal cell membranes, restoring membrane fluidity and stability through the formation of mobile drug-phospholipid complexes. This mechanism helps maintain the structural integrity and function of membrane proteins, enhancing neuronal communication and synaptic transmission. In addition to its neuroprotective effects, Piracetam also improves cerebral microcirculation and supports cognitive performance without producing significant vasodilatory effects.

The recommended daily dosage begins at 800 mg and may be gradually increased up to a maximum of 2400 mg per day, administered in two or three divided doses. Neurocetam Tablets may be taken with or without food, or as directed by the physician.

Neurocetam Tablets are contraindicated in patients with known hypersensitivity to Piracetam, other pyrrolidone derivatives, or any component of the formulation. It should also not be used in patients with cerebral hemorrhage, Huntington's chorea, or end-stage renal disease.